OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Commerce. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.
Click here to read the articles and download the PDF
While vendors fill in gaps in products and services for the supply chain, the action moves toward new cloud-based visibility systems.
The trend is continuing for brands and even for some specialty products.
Questions and considerations for pharmaceutical companies in designing and executing strategies to curb the incidence of fake drugs.
December 01, 2023
Ongoing clinical trials are evaluating zotatifin (eFT226) plus Faslodex (fulvestrant) and Verzenio (abemaciclib) for the treatment of ER–positive, HER2-negative advanced or metastatic breast cancer.
In clinical trials, Keytruda plus Padcev lowered the risk of disease progression or death by 55% compared with chemotherapy in adult patients with locally advanced or metastatic urothelial carcinoma.
November 30, 2023
Sphingosine-1-phosphate receptor modulator is designed to improve leukemia-free survival by increasing graft-versus-leukemia response.
In clinical trials, roflumilast cream demonstrated rapid and sustained improvement in the signs and symptoms of atopic dermatitis in patients 6 years of age and older.
The companies will partner up to design and implement solutions that support each other's business efforts.
November 29, 2023
In clinical trials, KarXT (xanomeline-trospium) demonstrated a combination of strong tolerability and clinically meaningful symptom reduction in adult patients with schizophrenia.
CDC finds administration rates for influenza antiviral medication was lower than during pre–COVID-19 pandemic flu seasons.
Pharma Commerce editor takes a look back at 2023's impressionable editorial content.
November 28, 2023
Biden Administration invokes Defense Production Act to facilitate domestic manufacturing of essential medicines.
Studies explore how both the UK and EU are handling these ongoing supply chain challenges.